Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study

BACKGROUND: Despite improvements in the management of renal cell carcinomas (RCC) with the advent of immunotherapy, only a few patients respond to these treatments. Predictors of response to nivolumab are currently being investigated but are still lacking. AIM OF THE STUDY: To evaluate eosinophil le...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrmann, Tressie, Ginzac, Angeline, Molnar, Ioana, Bailly, Sébastien, Durando, Xavier, Mahammedi, Hakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495279/
https://www.ncbi.nlm.nih.gov/pubmed/34405573
http://dx.doi.org/10.1002/cam4.4208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495279/
https://www.ncbi.nlm.nih.gov/pubmed/34405573
http://dx.doi.org/10.1002/cam4.4208

Ejemplares similares